Yahoo Finance • last month
Maravai LifeSciences Holdings LLC SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to an... Full story
Yahoo Finance • 3 months ago
Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO, August 28, 2024--(BUSINESS WIRE)--Cygnus... Full story
Yahoo Finance • 7 months ago
Maravai LifeSciences Holdings (NASDAQ:MRVI) First Quarter 2024 Results Key Financial Results Revenue: US$64.2m (down 19% from 1Q 2023). Net loss: US$12.1m (loss widened by US$12.0m from 1Q 2023). US$0.091 loss per share (further deterior... Full story
Yahoo Finance • 9 months ago
Participants Andrew Burch; President of Nucleic Acid Production; Maravai LifeSciences Holdings, Inc. Debra Hart; Senior Director of IR; Maravai LifeSciences Holdings, Inc. Kevin M. Herde; Executive VP & CFO; Maravai LifeSciences Holding... Full story
Yahoo Finance • 10 months ago
Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In 2023, the fund (Institutional Shares) returned 22.58% outperforming the 1... Full story
Yahoo Finance • last year
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor... Full story
Yahoo Finance • last year
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) reports a significant year-over-year revenue decrease in Q3 2023. The company announces a workforce reduction and cost realignment to improve operational efficiencies. Updated financial guida... Full story
Yahoo Finance • last year
In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into. If you want to skip our introduction to the biotechnology industry and how it might be affected by recent economic and stock market t... Full story
Yahoo Finance • last year
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 fin... Full story
Yahoo Finance • last year
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, hosted its 2023... Full story
Yahoo Finance • last year
SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Br... Full story
Yahoo Finance • last year
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 20... Full story
Yahoo Finance • last year
LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characterization of process-related impurities in... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6 . Th... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2023 fi... Full story
Yahoo Finance • 2 years ago
- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity & Inclusion and has an executive leade... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor... Full story
Yahoo Finance • 2 years ago
In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According... Full story
Yahoo Finance • 2 years ago
Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilitie... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and ful... Full story